<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336537">
  <stage>Registered</stage>
  <submitdate>15/02/2011</submitdate>
  <approvaldate>1/03/2011</approvaldate>
  <actrnumber>ACTRN12611000223932</actrnumber>
  <trial_identification>
    <studytitle>Efficacy of an oral herbal compound in treatment of acute anal fissure</studytitle>
    <scientifictitle>In patients with acute anal fissure, treatment with oral herbal remedies in comparison to placebo will alleviate signs and symptoms (pain, itching, bleeding) of patients.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>N/A</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Acute anal fissure</healthcondition>
    <conditioncode>
      <conditioncode1>Alternative and complementary medicine</conditioncode1>
      <conditioncode2>Herbal remedies</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Oral administration of one capsule 40 mg containing herbal compounds (mixture of salep and Ginger) three times a day (before breakfast, lunch and dinner) for 6 days</interventions>
    <comparator>Placebo capsules (made up of starch) with the same dose and route of administration</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Alleviation of pain and itching assessing by questionnaires containing questions about presence and severity of signs and symptoms correlated with fissure.</outcome>
      <timepoint>3 days after initiation of treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>anatomical improvement of anal fissure and recovery of bleeding assessing by questionnaires and physical exam.containing questions about presence and severity of signs and symptoms correlated with fissure.</outcome>
      <timepoint>6 days after initiation of treatment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with proven anal fissure with 4 weeks or lower from initiation of the disease.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Pregnant women
2. Patients with uncontrolled acute or systemic illnesses
3. Inflammatory bowl disease
4. Chronic fissure
5. Use of psychiatric medications due to acute psychiatric illness</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/03/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Iran, Islamic Republic Of</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Shiraz University of medical science, Deputy of research and technology</primarysponsorname>
    <primarysponsoraddress>Shiraz University of medical science-Zand AVe, Fars, IranP.C:71345-1845</primarysponsoraddress>
    <primarysponsorcountry>Iran, Islamic Republic Of</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Shiraz University of medical science-</fundingname>
      <fundingaddress>7th  floor, Deputy of research and technology, Shiraz University of medical sciences, Zand Ave, Shiraz, Fars province, Iran,
P.C:71345-1845</fundingaddress>
      <fundingcountry>Iran, Islamic Republic Of</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Kamran Bagheri Lankarani</sponsorname>
      <sponsoraddress>Health policy research center,5th floor, Shiraz medical school, Zand Ave, Shiraz, Fars province, Iran.
P.C: 71345-1877</sponsoraddress>
      <sponsorcountry>Iran, Islamic Republic Of</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Local ethical committe of Shiraz University of medical sciences</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Iran, Islamic Republic Of</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Kamran B Lankarani</name>
      <address>Health policy research center, 5th floor, Shiraz University of medical science, Zand Ave, Shiraz, Fars, Iran.
P.C: 71345-1877</address>
      <phone>0098 711 230 9615</phone>
      <fax />
      <email>lankaran@sums.ac.ir</email>
      <country>Iran, Islamic Republic Of</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ahad Eshraghian</name>
      <address>Internal medicine department, Namazi Hospital, Zand Ave, Shiraz, Fars, Iran
P.C 71345-1744</address>
      <phone>00989177311442</phone>
      <fax />
      <email>eshraghiana@yahoo.com</email>
      <country>Iran, Islamic Republic Of</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>